https://www.marketscreener.com/quote/stock/ALECTOR-INC-54379343/news/FDA-Grants-Latozinemab-Breakthrough-Therapy-Designation-for-Frontotemporal-Dementia-Due-to-a-Progran-45901975/?utm_source=telegram&utm_medium=social&utm_campaign=share